Ligand profile
PTG
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0681 — alpha/beta hydrolase fold family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
PTG- PDB
6i5g- UniProt (similar protein)
P34913- Target protein
- VK055_0681
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 54.4
- −1 ≤ LogP ≤ 5 5.01
- MW ≤ 500 Da 316.4
- LogP ≤ 5 5.01
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 11
- TPSA ≤ 140 Ų 54.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCC\C=C\C=C1[C@H](C=CC1=O)C\C=C\CCCC(=O)OCCCCC\C=C\C=C1[C@H](C=CC1=O)C\C=C\CCCC(=O)O
InChI=1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7+,10-6+,18-13?/t17-/m0/s1InChI=1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7+,10-6+,18-13?/t17-/m0/s1
VHRUMKCAEVRUBK-BZGMIIDWSA-NVHRUMKCAEVRUBK-BZGMIIDWSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PTG →
- PDB RCSB structure 6i5g →
- UniProt UniProt P34913 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PTG”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0681.
PDB 98
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).